Illudin S, a natural product isolated from mushrooms and various derivatives, have generally been demonstrated to possess several properties that make them unique as potential antitumor agents. In sensitive tumor cell types, illudin S has been shown to be a potent inhibitor of DNA synthesis that causes cell cycle arrest in S phase and retains antitumor activity against a broad range of drug-resistant tumor cell lines in vitro. Illudin S is also actively taken up by sensitive tumor cell types and damages the DNA in a unique manner that appears to require functional DNA helicase activity for DNA repair process to occur. MGI 114, 6-hydroxymethylacylfulvene (HMAF), is one of the analogs synthesized that was found to exhibit excellent in vitro and in vivo antitumor activity. Our hypothesis is that MGI 114, a synthetic derivative of the illudin S, has improved therapeutic margins and is believed to have potent effects on the synthesis of DNA that will cause the arrest in S phase. The primary objective of this study is to determine the maximum tolerated dose of MGI 114 administered intravenously once daily for five days every 28 days in patients with advanced cancer. Secondary objectives are to determine the toxicities associated with administration of MGI 114, determine the pharmacokinetics of MGI 114, and to determine the antitumor capabilities of MGI 114.

Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
14
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Burgess-Hull, Albert J; Roberts, Linda J; Piper, Megan E et al. (2018) The social networks of smokers attempting to quit: An empirically derived and validated classification. Psychol Addict Behav 32:64-75
Kelly, Elizabeth A; Esnault, Stephane; Liu, Lin Ying et al. (2017) Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma. Am J Respir Crit Care Med 196:1385-1395
Shen, Zhong-Jian; Hu, Jie; Kashi, Venkatesh P et al. (2017) Epstein-Barr Virus-induced Gene 2 Mediates Allergen-induced Leukocyte Migration into Airways. Am J Respir Crit Care Med 195:1576-1585
Anderson, Halie M; Lemanske Jr, Robert F; Evans, Michael D et al. (2017) Assessment of wheezing frequency and viral etiology on childhood and adolescent asthma risk. J Allergy Clin Immunol 139:692-694
Gomez, Jose L; Yan, Xiting; Holm, Carole T et al. (2017) Characterisation of asthma subgroups associated with circulating YKL-40 levels. Eur Respir J 50:
Kelly, Elizabeth A; Esnault, Stephane; Johnson, Sean H et al. (2016) Human eosinophil activin A synthesis and mRNA stabilization are induced by the combination of IL-3 plus TNF. Immunol Cell Biol 94:701-8
Bray, Bethany C; Smith, Rachel A; Piper, Megan E et al. (2016) Transitions in Smokers' Social Networks After Quit Attempts: A Latent Transition Analysis. Nicotine Tob Res 18:2243-2251
Dougherty, Ryan J; Ellingson, Laura D; Schultz, Stephanie A et al. (2016) Meeting physical activity recommendations may be protective against temporal lobe atrophy in older adults at risk for Alzheimer's disease. Alzheimers Dement (Amst) 4:14-7
Johansson, Mats W; Evans, Michael D; Crisafi, Gina M et al. (2016) Serum periostin is associated with type 2 immunity in severe asthma. J Allergy Clin Immunol 137:1904-1907.e2
Gerald, Joe K; Gerald, Lynn B; Vasquez, Monica M et al. (2015) Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent Asthma. J Allergy Clin Immunol Pract 3:540-6.e3

Showing the most recent 10 out of 459 publications